Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients

Oncotype Dx is used to determine the recurrence risk (RR) in patients with estrogen receptor positive (ER+) and lymph node negative (LN−) breast cancer. The RR is divided into low (0–17), intermediate (18–30), and high (31) to predict chemotherapy benefit. Our goal was to determine the association b...

Full description

Saved in:
Bibliographic Details
Published in:Int J Breast Cancer
Main Authors: Hanna, Matthew G., Bleiweiss, Ira J., Nayak, Anupma, Jaffer, Shabnam
Format: Artigo
Language:Inglês
Published: Hindawi Publishing Corporation 2017
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266836/
https://ncbi.nlm.nih.gov/pubmed/28168058
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/1257078
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items